BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27047800)

  • 1. Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life.
    Raziee H; Berlin A
    Front Oncol; 2016; 6():70. PubMed ID: 27047800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
    Loeb S; Roehl KA; Viprakasit DP; Catalona WJ
    Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
    Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
    J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
    Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
    Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant versus early Salvage radiation therapy for prostate cancer with adverse pathological features on radical prostatectomy-Do we finally have an answer?
    Jain S; Mallick I; Tamhankar AS; Gautam G
    Indian J Cancer; 2022; 59(2):170-177. PubMed ID: 35946183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
    Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
    BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
    Kneebone A; Fraser-Browne C; Duchesne GM; Fisher R; Frydenberg M; Herschtal A; Williams SG; Brown C; Delprado W; Haworth A; Joseph DJ; Martin JM; Matthews JHL; Millar JL; Sidhom M; Spry N; Tang CI; Turner S; Wiltshire KL; Woo HH; Davis ID; Lim TS; Pearse M
    Lancet Oncol; 2020 Oct; 21(10):1331-1340. PubMed ID: 33002437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant vs. salvage radiotherapy after radical prostatectomy].
    Bartkowiak D; Schrader AJ; Wiegel T
    Aktuelle Urol; 2015 Jan; 46(1):52-8. PubMed ID: 25658231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer.
    Şendoğan F; Turan T; Keser F; Hancilar T; Atis G; Yildirim A
    Cent European J Urol; 2023; 76(2):109-115. PubMed ID: 37483851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHICH PATIENTS SHOULD RECEIVE RADIOTHERAPY IN POSTOPERATIVE DISEASE RECURRENCE?
    Matić M; Matić S
    Acta Clin Croat; 2019 Nov; 58(Suppl 2):42-45. PubMed ID: 34975197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer.
    Ravi P; Kwak L; Devlies W; Xie W; Chipidza F; Yang X; Bubley G; Kaplan I; Kibel AS; Nguyen P; Taplin ME
    Prostate; 2024 Mar; 84(4):342-348. PubMed ID: 38041475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
    Vogel MME; Kessel KA; Schiller K; Devecka M; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Nov; 14(1):198. PubMed ID: 31711524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
    Fukuda I; Aoki M; Kimura T; Ikeda K
    Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.
    Casas F; Valduvieco I; Oses G; Izquierdo L; Archila I; Costa M; Cortes KS; Barreto T; Ferrer F
    Clin Transl Oncol; 2019 Mar; 21(3):355-362. PubMed ID: 30128953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
    Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Tomaszewski JE; Wein A
    Cancer; 2000 May; 88(9):2110-5. PubMed ID: 10813723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy after radical prostatectomy: immediate or early delayed?
    Bottke D; Bartkowiak D; Schrader M; Wiegel T
    Strahlenther Onkol; 2012 Dec; 188(12):1096-101. PubMed ID: 23128897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.